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Abstract
Mammalian DNA polymerase d (pol d), a four-subunit enzyme, plays a crucial and versatile role in DNA replication and
various DNA repair processes. Its function as a chromosomal DNA polymerase is dependent on the association with
proliferating cell nuclear antigen (PCNA) which functions as a molecular sliding clamp. All four of the pol d subunits (p125,
p50, p68, and p12) have been reported to bind to PCNA. However, the identity of the subunit of pol d that directly interacts
with PCNA and is therefore primarily responsible for the processivity of the enzyme still remains controversial. Previous
model for the network of protein-protein interactions of the pol d-PCNA complex showed that pol d might be able to
interact with a single molecule of PCNA homotrimer through its three subunits, p125, p68, and p12 in which the p50 was
not included in. Here, we have confirmed that the small subunit p50 of human pol d truthfully interacts with PCNA by the
use of far-Western analysis, quantitative ELISA assay, and subcellular co-localization. P50 is required for mediation of the
interaction between pol d subassemblies and PCNA homotrimer. Thus, pol d interacts with PCNA via its four subunits.
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Introduction
Chromosomal DNA replication in eukaryotes requires at least
three major DNA replicative polymerases: a (pol a), d (pol d), and e
(pol e). Current views of the eukaryotic replication indicate that pol
a/primase synthesizes RNA primers plus short stretches of DNA to
initiate Okazaki fragment synthesis, and the actual elongation of
RNA-DNA primers is performed by pol d (but not pol e) in a process
termed ‘‘polymerase switching’’ that involves replication factor C
(RFC) and proliferating cell nuclear antigen (PCNA) [1,2,3,4].
However,pold isalso capableofperforming leading strand synthesis
[5,6]. The roles of pol e in replication are still not completely clear.
Studies in budding yeast indicate that pol e may function in
mammalian DNA replication, synthesizing most of the DNA on the
leading strand template [7,8]. Although we do not know just how
interchangeablethe functionsofpol d and pol e areat the replication
fork in vivo, clearly both are involved in chromosomal replication.
They may do so in roles that are specific or overlapping in the
various processes involved in chromosomal replication besides
replication of DNA, which range from replication initiation, sister
chromatidcohesion,thenatureofthechromatinthatisencountered,
and DNA damage checkpoint responses [5,9,10].
The subunit composition of pol d has been controversial and
may vary among different eukaryotes. In yeast, S. pombe pol d
consists of four subunits, Pol3, Cdc1, Cdc27 and Cdm1
[11,12,13]. While S. cerevisiae pol d is a trimer of the first three
subunits, Pol3p, Pol31p/Hys2, and Pol32p [14,15]. The smallest
non-essential subunit Cdm1 has no apparent homologue in
budding yeast [13]. The mammalian pol d was initially
characterized as a two-subunit complex of 125 kDa and 50 kDa
[16,17,18,19]. The p125 catalytic subunit, containing both the
polymerase and exonuclease catalytic domain, is homologous to
fission yeast Pol3 and budding yeast Pol3p, whereas the small
subunit p50 is a homologue of Cdc1 and Pol31p/Hys2. It was
later shown that mammalian pol d has two additional subunits,
p68 and p12 [20,21,22,23]. Thus, similar to S. pombe enzyme, the
mammalian pol d consists of at least four subunits, forming a
heterotetrameric complex.
Maintaining high-fidelity chromosomal DNA replication is
essential for the preservation of genomic integrity and avoidance
of the mutations which can lead to disease. Mammalian cells
respond to DNA damage by a host of defense mechanisms which
include activation of cell cycle checkpoints and DNA repair
mechanisms [24,25]. In addition to its crucial role in DNA
replication, pol d also plays a significant role in DNA repair, and is
generally regarded as the primary enzyme which performs re-
synthesis (gap-filling) in various DNA repair processes [5,24,26].
The subunit composition of pol d complex in vivo may vary with
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genotoxic agents trigger the degradation of the p12 subunit, pol d
is consequently converted from a heterotetramer (p125/p50/p68/
p12) to a trimer (p125/p50/p68) lacking the p12 subunit [27].
This converted trimer has altered enzymatic properties with a less
activity to perform translesion synthesis when it encounters DNA
base lesions, a greater proofreading ability for the insertion of
wrong nucleotides and extension of mismatched primers, and
enhanced ability for the detection of errors in both primers and
templates over its parent enzyme [28]. More recent studies
indicate that this trimer is more likely to mediate single-nucleotide
base excision repair (SN BER) in uracil-intiated BER in vitro [29].
These alterations of enzymatic property may be partly due to the
loss of p12 subunit, resulting in a conformational change of pol d,
which alters its fidelity by modulating the rate and proofreading 39
to 59 exonuclease activity, a more rapid and frequent transfer of
the DNA primer from the catalytic center to the exonuclease
active center [30].
The function of pol d as a chromosomal DNA polymerase is
dependent on its association with PCNA which functions as a
molecular sliding clamp here. PCNA also plays a crucial and
versatile role in many DNA transactions where it acts as a scaffold
for the recruitment and organization of protein complexes which
involve DNA transactions both in DNA replication and repair.
However, the identity of the subunit of pol d which directly
interacts with PCNA and is therefore primarily responsible for the
processivity of the enzyme remains controversial. All four subunits
of pol d have been reported to contain a PCNA-binding motif and
the interaction of each subunit with PCNA has been suggested to
be primarily responsible for the high processivity of pol d
[20,23,31,32,33]. These observations are consistent with that the
interactions of human pol d with PCNA are likely to be
multivalent, but leaves open the questions of which, or how
many, of the subunits are involved in the interaction with PCNA
during DNA replication or repair processes; whether multiple
arrangements of pol d and PCNA exist in vivo, and whether these
may be involved in the different process in which both pol d and
PCNA play a role. Previously, we proposed a model for the
network of protein-protein interactions of the pol d-PCNA
complex in which the pol d might be able to interact with a
single molecule of PCNA homotrimer through its three subunits,
p125, p68, and p12 [31]. We had not been able to confirm the
interaction of p50 with PCNA at that time because the weakest
binding of the p50 to PCNA. In this work we have re-examined
the interaction of p50 with PCNA using far-Western analysis,
quantitative ELISA assay, and subcellular co-localization. Our
results indicate that the small subunit p50 of human pol d indeed
interacts with PCNA. We have also modified the model of protein-
protein interactions of the pol d-PCNA complex to include p50 in
which pol d interacts with PCNA via its four subunits.
Materials and Methods
Reagents and chemicals
All reagents and chemicals used in this study were purchased
from Sigma-Aldrich, Gibco-BRL, and Invitrogen except as
otherwise indicated. A rabbit polyclonal antibody against p50
was prepared in this work. A mouse monoclonal antibody against
PCNA (PC-10) was obtained from Santa Cruz Biotechnology.
Production of polyclonal antibody
For immunogen preparation, the GST-tagged p50 was
generated by the PCR using the plasmid pCDNA3.1(+)-FLAG
containing a full-length p50 as a template [34]. The generated
PCR fragments were digested with BamHI and EcoRI, subcloned in-
frame into the BamHI-EcoRI sites of pGEX-5X-3, and sequenced.
The primer pairs used here were as follows: Forward, 59-CGCGG-
ATCCGCATGTTTTCTGAGCAGGCTGCC-39; Backward, 59-
CCGGAATTCTCAGGGGCCCAGCCCCAGGCC-39 (the BamHI
and EcoRI sides are underlined, respectively). The generated clones
were transformed into E. coli DH5-a cells.
GST-tagged p50, expressed in one liter of DH5-a cells
harboring full-length p50 of human pol d in vector pGEX-5X-3,
was purified on glutathione-Sepharose 4B beads (Amersham
Pharmacia Biotech). Non-tagged p50, used as antigen, was
released by proteolysis with Factor Xa and the glutathione S-
transferase was removed with glutathione-Sepharose. Released
fractions of non-tagged p50 were combined and then purified by
FPLC chromatography on Mono Q 5/50 GL column (GE
Healthcare). The highly purified protein was analyzed by mass
spectrometry to further confirm amino acid sequence before
immunization.
The polyclonal antibody against small subunit p50 of human
pol d was produced by immunizing rabbits with highly purified
non-tagged p50 protein. The collected antiserums were precipi-
tated at 40-50% saturation of (NH4)2SO4 and followed by the low-
salt purification on a column packed with 5-ml Pierce Protein A/G
Plus Agarose as described [35].
Mass spectrometry analysis
The specific bands corresponding to human pol d small subunit
p50 protein were excised manually from the polyacrylamide gel
with a sterile scalpel and digested with trypsin according to Li’s
method [36]. The digested samples were analyzed by an ultraflex
MALDI-TOF–TOF instrument (Bruker, Germany). Peptide mass
fingerprinting (PMF) was performed by comparing the masses of
identified peptides to NCBI protein database using the MASCOT
search engine (http://www.matrixscience.com).
Purification of His-tagged protein and human pol d four-
subunit complex
His-tagged p68 expressed in E. coli BL21DE3(plys) was purified
by the use of nickel-nitrilotriacetic acidagarose (Qiagen) and
further purified by ion exchange chromatography on FPLC Mono
Q column (GE Healthcare) as described previously [31]. The
protocol for rapid isolation of recombinant pol d four-subunit
complex generated from Bombyx mori bioreactor was as described
[29].
Digoxigenin (DIG)-labeling of PCNA
The recombinant human PCNA expressed in E. coli was
purified to near homogeneity by a protocol as previously described
[29,37]. Highly purified PCNA was then labeled using the DIG
Protein Labeling Kit (Roche Diagnostics) according to the
manufacture’s instructions.
Far-Western blotting — Overlay Blotting with PCNA-DIG
PCNA-DIG overlay for the detection of the interaction between
p50 and PCNA was performed as described previously by the use
of DIG-labeled PCNA as a probe [38]. Increasing amounts of
non-tagged p50 or purified pol d4 complex from Bombyx mori
bioreactor [29] were run on 12% SDS-PAGE and transferred to
nitrocellulose membranes. The buffers used in the overlay
experiment were purchased from the manufacturer (Roche
Diagnostics). The membranes were blocked with 1x blocking
solution in 1x Maleic acid buffer overnight at 4uC, washed for 10
minutes with 1x washing buffer, and incubated with DIG-labeled
p50 Directly Interacts with the PCNA
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PCNA-DIG stock). The membranes were washed with 3x30
minutes with washing buffer, incubated with Anti-DIG-HRP at
1:10,000 dilutions in 100 mM Tris-HCl, pH 7.5/150 mM NaCl,
followed by 3x20 minutes washing with washing buffer. The
signals were detected using enhanced chemiluminescence lighting,
ECL (Pierce) and the membranes were exposed to film.
Enzyme-linked Immunosorbent Assay (ELISA) for
detection of p50-PCNA protein-protein interactions
The ELISA for the protein-protein interactions was basically
described as [31]. Briefly, purified non-tagged p50 and His-p68 (as
a positive control) were diluted to a concentration of 0.001 mg/ml
in carbonate buffer, pH 9.6. Each 100 ml of dilutions was added to
the wells of a 96-well ELISA plate and allowed to coat overnight at
4uC. For the control experiment, BSA was substituted for subunits
in the coating step. Wells were rinsed three times with ELISA
buffer (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 0.5% Tween-
20), then blocked with ELISA buffer containing 3% BSA by
incubating plate for 2 hours at room temperature. Increasing
amounts of PCNA in ELISA buffer containing 1% BSA were
added to appropriate wells and allowed to be incubated at 4uC
overnight. Wells were emptied and washed four times with ELISA
buffer. The primary mouse monoclonal antibody against PCNA
(PC-10) was diluted at 1:2000 in ELISA buffer containing 1%
BSA, added to each well, and incubated for one hour at room
temperature. The plate was then washed four times with ELISA
buffer. The secondary antibody of goat anti-mouse IgG-horserad-
ish peroxidase (Pierce) was diluted at 1:5,000 in ELISA buffer
containing 1% BSA and added to appropriate wells to incubate for
30 minutes at room temperature. Wells were rinsed five times with
ELISA buffer. The signals were detected using TMB substrate
(Pierce) and then quenched with 1 N sulfuric acid for 10 minutes.
Absorbance readings were taken at 450 nm. ELISA was also
performed by coating a 96-well plate with 100 ng of purified
recombinant human PCNA and adding increasing amounts of
non-tagged p50, His-p68, or BSA. The rabbit polyclonal antibody
against p50 or p68 [29] was used to detect bound p50 or His-p68
to PCNA, respectively.
Western blot analysis to test the efficiency of obtained
polyclonal antibody
A western blot protocol for testing the efficiency of obtained
polyclonal antibody was as described previously [29]. An
electrophoresis was performed by loading 100 mg each well of
Hela cell total lysate onto 12% SDS-PAGE and separated proteins
were transferred to a nitrocellulose membrane. The membrane
was then stained with Ponceau S and cut into several pieces
corresponding to each loading well. These pieces of membrane
were blocked with 5% w/v nonfat dry milk in TBST buffer
(20 mM TrisHCl, pH 7.4, 150 mM NaCl, 0.05% Tween 20) for
one hour at room temperature. The slices were then incubated
with decreasing amounts of antibody concentration for one hour
at room temperature at 4uC. After three 15-min washes in TBST,
the slices were incubated with AP-conjugated goat anti-rabbit IgG
(Pierce) for one hour and washed with TBST 3 times for 10 min.
Perfect Protein Western Blot Kit (Novagen) was used for signal
generation.
Immunocytochemistry
Immunocytochemistry was performed as described previously
[34]. HeLa cells were grown in 4-well slides and fixed with 100%
methanol and further permeabilized with 0.1% Triton X-100 in
PBS. Endogenous p50 was immunostained with purified anti-p50
rabbit polyclonal antibody at optimized concentration in 2%
BSA/PBS for one hour at room temperature and washed three
times with PBS. Endogenous PCNA was immunostained with
anti-PCNA mouse monoclonal antibody (PC-10) at 1: 200
dilutions, washed three times with PBS, and then incubated with
Rhodamine-X-conjugated anti-rabbit IgG (Red) and Alexa-
fluor488-conjugated (green) anti-mouse IgG (Jackson ImmunoR-
esearch) at room temperature for one hour in the dark. DNA was
counterstained with DAPI. Slides were viewed on an Axiovert 200
M fluorescence microscope (Zeiss) and analyzed with the
Axiovision software (Zeiss).
Protein concentration determination
Protein concentrations were determined by the Bradford
method with bovine serum albumin (BSA) as a standard, or by
‘‘in-gel’’ determination using catalase as a protein standard [28].
Results and Discussion
Production of polyclonal antibody against human pol d
small subunit p50
Our initial effort for polyclonal antibody production with
purified His-tagged fusion p50 as antigen which was expressed in
E. Coli cells harboring full-length p50 in pET-28b(+) vector was
unsuccessful because of the lower sensitivity and specificity of the
obtained antibody, which may due to the quality of the
immunogen. The purified His-tagged fusion protein was not pure
enough as immunogen for the purpose of immunization by the
purification on nickel-nitrilotriacetic acidagarose beads and further
on Mono Q 5/50 GL column only. Alternatively, we chose non-
tagged p50 in its native form as immunogen by construction of
full-length p50 fragment into pGEX-5X-3 vector (Figure 1A),
expression of GST-tagged p50 in E. Coli and purification on
glutathione-Sepharose 4B beads (Figure 1B), release of non-tagged
p50 with Factor Xa protease from fusion proteins which are bound
to Glutathione Sepharose 4B beads (Figure 1C), and further
purification of released fractions of non-tagged p50 on FPLC
Mono Q column (Figure 1D). About 4 mg of highly purified p50
protein from one liter of DH5-a cells was obtained. The amino
acid sequence of obtained protein was further verified by mass
spectrometry (Figure 2). Fifteen peptide fragments were identified
with MOWSE score of 100 and matched against the deduced
amino acid sequence of p50 with 34% sequence coverage.
After immunizing two New Zealand rabbits using our highly
purified non-tagged p50 protein as immunogen, about 200 mg of
polyclonal antibody was purified in high purity from about 120 ml
of collected antiserum (final termination bleeds) by the precipita-
tion of (NH4)2SO4 and further on a Protein A/G Plus Agarose
packed column (Figure 3A). The efficiency of obtained antibody
was tested by Western blotting using Hela cell extracts. Optimized
concentration of purified antibody at 0.05–0.1 mg/ml could result
in a high sensitivity for detecting the interaction between antibody
and endogenous p50 subunit of human pol d in good specificity
(Figure 3B, lane 5 and 6).
A direct interaction of p50 with PCNA was confirmed by
far-Western blotting- PCNA-DIG overlay
Despite the fact that PCNA was first identified as a processivity
factor for pol d about 25 years ago [39], the identity of the subunit
of pol d that directly interacts with PCNA and is therefore
primarily responsible for the processivity of the enzyme remains
controversial. It seems that all four subunits of the pol d interact
with PCNA by the perusal of the literature mentioned in
p50 Directly Interacts with the PCNA
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binding should be a weakest one comparing with other subunits’
that is probably why we could not confirm it before. Here, we
applied a more sensitive approach to the testing of direct
interaction between p50 and PCNA, far-Western analysis. The
recombinant PCNA expressed in one liter of DH5-a cells
harboring human PCNA in pTACTAC vector [29] was purified
to near homogeneity by a Q-sepharose column and then further
by FPLC chromatography on a 4-ml Mono P HR 5/20 column.
The elution behavior of PCNA on Mono P was shown in Figure 4.
The peak fraction 51 was used for the labeling of digoxigenin. The
final DIG labeled PCNA solution was obtained with the
concentration of 0.15 mg/ml. Highly purified non-tagged p50
and recombinant four-subunit complex of human DNA pol d from
silkworm bioreactor [29] were loaded at increasing amounts onto
12% SDS-PAGE and then transferred onto nitrocellulose
membranes. The transferring efficiency of separated proteins onto
membranes was judged by Ponceau S staining (Figure 5A and 5C).
The membranes were then subjected to the PCNA overlay assay.
As shown in Figure 5D, PCNA directly bound to the subunit p125,
p68, and p12, which are in agreement with the previous reports.
Surprisingly, p50 can also interact with PCNA which was judged
by the bound PCNA both on the non-tagged p50 (Figure 5B) and
on p50 subunit of pol d complex (Figure 5D, the piece of film for
p50). Although its binding is weaker than other subunits’, the p50-
PCNA interaction still could be clearly observed by a slight
overexposure of the films which allow visualization of bound
PCNA. This is the first time we confirmed the direct interaction of
p50 with PCNA because of its weaker binding.
It should be noted that in our experimental condition, PCNA
exhibited strong interaction with a number of truncated products,
especially between 19 KDa and 34 KDa (Figure 5B), which is not
visible by Ponceau staining (Figure 5A). Previous study revealed
that a synthesized peptide fragment containing the N-terminal
MRPFL sequence of p50, a homologue of sliding clamp binding
motif of RB69 DNA polymerase (LFDMF) and T4 DNA
polymerase (LDFLF), appeared strong competition with p50 for
binding to PCNA [33]. Many bands other than p50’s shown in our
far-Western assay suggested that our purified non-tagged p50 from
E. coli expression is not pure enough. It contained a lot of
contaminants with MRPFL-like sequence which might compete
with p50 for binding to PCNA, which could account for the bands
between 19 KDa and 34 KDa in our far-Western assay. Strong
interactions of PCNA with a dizzying variety of partners suggested
that PCNA may have other, as yet unknown, functions besides its
role as a ‘‘sliding clamp’’, a mobile platform for the docking of an
impressive array of enzymes responsible for the replication and
repair of DNA.
The interaction of p50 with PCNA was further verified by
quantitative ELISA assays
In order to further verify the interaction between p50 and
PCNA, the quantitative ELISA assays were performed. The
purified non-tagged p50 (Figure 6A, lane 2), His-p68 which was
used as a positive control (Figure 6A, lane 1), and BSA which was
used as a negative control were coated onto a 96-well ELISA plate,
adjusting proteins to 100 ng per well. Increasing amounts of
PCNA were then added to protein-coated wells. The bound
PCNA was detected by mouse monoclonal antibody PC-10. As
shown in Figure 6B, PCNA bound to the wells coated with p50
with a linear response following the increase of PCNA amounts
from 0 to 4 mg per well. Absorbance readings at 450 nm indicated
a relative weaker interaction of PCNA-p50, i.e., 21% of that for
PCNA-p68. Alternatively, a 96-well plate was coated with purified
PCNA, and increasing amounts of non-tagged p50, His-p68, or
BSA were then added. The bound p50 or His-p68 to PCNA was
detected by the rabbit polyclonal antibodies against p50 (in this
work) or anti-p68 [29]. Absorbance readings at 450 nm showed
that p50 bound to PCNA-coated wells also as a linear response
following the increase of p50 concentration from 0 to 2 mM while
only small amount of His-p68, only 0.025 mM, brought interaction
of p68-PCNA to a saturation level (Figure 6C). In such case,
although two interaction levels could not be directly comparable
because it depends on the sensitivity of antibodies in which two
different antibodies were used to detect bound His-p68 and p50 to
PCNA-coated wells. Nevertheless, these data proved that p50
indeed interacts directly with PCNA although this binding level is
relatively weak.
The intracellular localization of p50 and PCNA provides
an evidence for a possible physical interaction between
p50 and PCNA in vivo
Many proteins have been identified which interact with PCNA
in which PCNA acts as an assembly platform for the replica-
tion machinery. The third subunit p68 was shown to be a nuclear
protein which was excluded from the nucleolus and was local-
ized to replication foci during S phase [40]. These foci or
factories represent a conglomeration of proteins involved in DNA
replication and post-replicative processing which are brought
together at sites of DNA replication. This pattern of localization
Figure 1. Analysis for the preparation of the immunogen for
the production of polyclonal antibody against small subunit
p50 of human DNA pol d.A :Agarose gel electrophoresis. M, DNA
marker in bp; Lane 1, a selected colony of pGEX-5X-3-p50 digested with
BamHI and EcoRI. B: Coomassie Blue stained SDS-PAGE analysis for the
purification of GST-p50 protein on glutathione-Sepharose 4B column.
The lysates (BC), flow-through (FT), and eluted fractions were analyzed
on 12% SDS-PAGE followed by Coomassie Blue staining. Protein maker
is indicated in lane M as kDa. The position of GST-p50 protein is
indicated by an arrow. C: Coomassie Blue stained SDS-PAGE analysis for
release of non-tagged p50 by Factor Xa. Lane 1-4: fractions of released
p50; Lane 5: the beads containing GST and unreleased p50 after
digestion reaction. D: Coomassie Blue stained SDS-PAGE analysis for the
peak fractions of released p50 protein further purified on Mono Q
column.
doi:10.1371/journal.pone.0027092.g001
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such as PCNA, pol a, Fen1, DNA ligase I, RFC, RPA etc
[41,42].
Figure 2. MALDI spectra of tryptic digestion of recombinant p50 subunit of human DNA pol d. The identified protein, score, amino acid
sequence coverage and the number of identified peptides are shown. The sequences of identified peptides shown in bold red covered 34%
sequences against the deduced amino acid sequence of p50.
doi:10.1371/journal.pone.0027092.g002
Figure 3. Analysis for the production of polyclonal antibody. A:
Coomassie Blue stained SDS-PAGE analysis for the purification of
polyclonal antibody against p50 after affinity chromatography on a 5-ml
Protein A/G Plus column. The dialyzed sample in PBS after ammonium
sulfate precipitation (Bc), flow-through (Ft), wash (W1 and W2), and
eluted fractions were analyzed on 12% SDS-PAGE followed by
Coomassie Blue staining. Protein marker in kDa is indicated by ‘‘M’’.
The heavy and light chains are marked by arrows. B: Measurement of
sensitivity and specificity of purified antibody by Western blotting with
Hela cell extracts. The six lanes show decreasing concentrations of
antibody contained 0.8, 0.4, 0.2, 0.1, 0.05 (lane 2-6), and 0 mg/ml (lane 1)
of antibody/slice membrane, respectively. The detected endogenous
p50 is marked by an arrow.
doi:10.1371/journal.pone.0027092.g003
Figure 4. Coomassie Blue stained SDS-PAGE analysis for the
purification of recombinant human PCNA after FPLC chroma-
tography on Mono P column. Wild-type PCNA from the expression
of one liter of DH5-a cells was purified on Q-sepharose column.
Collected peak fractions were further purified on 4-ml Mono P HR 5/20
column. The starting material dialyzed in TGEED (Bc), flow-through (Ft),
wash (W), and eluted fractions (45-75) were analyzed on 12% SDS-PAGE
followed by Coomassie Blue staining. Protein marker is indicated in kDa
by ‘‘M’’. the position of PCNA is indicated by an arrow.
doi:10.1371/journal.pone.0027092.g004
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with PCNA in vivo, we investigated their intracellular localization
in cultured cells. The cultured Hela cells were pre-extracted with
100% methanol, which would remove soluble PCNA, leaving only
molecules involved in DNA replication. The anti-p50 polyclonal
antibody used here specifically recognized one major band
migrating with apparent molecular size slightly larger than 50
kDa at 0.05-0.1 mg/ml of the antibody concentration when total
lysates of HeLa cells were immunoblotted (Figure 3B, lane 5 and
6). The subcellular co-localization of endogenous p50 and PCNA
to the nuclear region (Figure 7C) by DAPI staining was clearly
observed on microscopy which was in a pair-wise fashion by
indirect immunofluorescence when the Hela cells were co-stained
with anti-PCNA mouse monoclonal antibody and anti-p50 rabbit
polyclonal antibody (Figure 7). The endogenous p50 localized to
distinct nuclear spots which are typical of replication foci
(Figure 7A). It looks likely that the observed subcellular
localization of p50 is similar to the pattern of localization of p68
in U2OS cells [40], localized to DNA replication foci. This
observation strongly supports a possible direct physical interaction
between p50 and PCNA in vivo. However, the nature of which p68,
or p50, or both is mainly required for mediation of the interaction
between pol d subcomplex(es) and PCNA during DNA replication
in vivo is still needed to be further investigated in which the
replication foci should be visualized more clearly by a proper
approach, for example, pulse-labeling cells with BrdU and staining
nuclei with a fluorescent antibody against BrdU after DNase
treatment.
There is some evidence to support an assumption that there
may exist multiple subassemblies of pol d in vivo. Pol d could be
converted from heterotetramer to a heterotrimer through the
degradation of the p12 subunit in cultured mammalian cells in
which this heterotrimer could be isolated as an intact complex
Figure 5. Far-Western analysis to detect the binding of PCNA
to p50. Highly purified non-tagged p50 (Figure 6A, Lane 2) and pol d4
[29] were run on 12% SDS-PAGE gel. Separated proteins were
transferred onto nitrocellulose membrane and stained with Ponceau
S. A: Lane 1-3 shows loaded 0.25, 0.5, 1 mg of p50. C: Lane 1-3 shows
loaded 0.125, 0.25, 0.5 mg (based on p50) of recombinant pol d4. The
membranes were then subjected to PCNA-DIG overlay assay as
described in ‘‘Materials and Methods’’. The signals were detected by
ECL and the membranes were exposed to the films. B: Exposure of the
film for p50 which exactly corresponds to Ponceau S stained membrane
of panel A. D: Exposure of the films for individual four subunits of pol d,
respectively, which exactly correspond to Ponceau S stained membrane
of panel C. Exposure of the film for p50 in both panel B and panel D was
slightly higher than those used for other subunits. Protein marker is
indicated in kDa by ‘‘M’’. Four subunits of pol d are indicated by arrows.
doi:10.1371/journal.pone.0027092.g005
Figure 6. Quantitative ELISA assay to verify the interaction of
p50 with PCNA. A: Coomassie blue stained SDS-PAGE analysis for the
highly purified proteins used in ELISA assays. M, protein marker in kDa;
Lane 1, highly purified His-p68. Lane 2, highly purified non-tagged p50.
B: Interaction of p50 with PCNA by adding PCNA to coated p50. The
assays were performed as described in ‘‘Materials and Methods’’. The
96-well plates were coated with 100 ng of p50, His-p68 and BSA. ELISAs
using increasing amounts of PCNA (horizontal axis) were then
performed using an antibody PC-10 to detect the bound PCNA to
p50. The p68 was taken as positive control while BSA was taken as
‘‘noise’’. Absorbance readings were taken at 450 nm and the values
were plotted after subtraction of the control values with BSA. Each
assay was performed three times and the standard deviations are
shown by the error bars. C: Interaction of p50 with PCNA by adding p50
to coated PCNA. The 96-well plate was pre-coated with 100 ng of PCNA.
Increasing amounts of 50, His-68 (as a control), or BSA were then added
(horizontal axis). Bound proteins to PCNA were recognized by an
antibody against p50 or p68 to detect the interaction between PCNA
and p50 or p68.
doi:10.1371/journal.pone.0027092.g006
Figure 7. Co-nuclear staining of p50 and PCNA. Hela cells were
fixed, permeabilized, and co-stained for p50 and PCNA using indirect
immunofluorescence in which an anti-p50 rabbit polyclonal antibody
was used for p50 while an anti-PCNA mouse monoclonal antibody PC-
10 was used for PCNA. A: Rhodamine-X-conjugated anti-rabbit IgG
secondary antibody was used for p50 (red). B: Alexafluor488-
conjugated anti-mouse IgG secondary antibody was used for PCNA
(green). C: DNA was counterstained with DAPI immunofluorescence
(blue). D: Merger for p50 (panel A) and DAPI (panel C). E: Merger for
p50 (panel A) and PCNA (panel B). F: Merger for p50 (panel A), PCNA
(panel B), and DAPI (panel C). Cells were analyzed and photographed
with an Axiovert 200 M fluorescence microscope (Zeiss).
doi:10.1371/journal.pone.0027092.g007
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heterotetrimer could be converted to a two-subunit complex as
a core enzyme form of p125/p50 through the cleavage of p68 and
p12 by human calpain-1 (unpublished data). Another phenome-
non also suggested this assumption. The recombinant human pol d
could be assembled in a silkworm bioreactor as multiple complexes
and these subassemblies could be isolated as dimer (p125/p50),
trimer lacking p12, and four-subunit complex, respectively, in
different eluted fractions on FPLC Mono Q chromatography [29].
Thus, an interconversion between the pol d heterotetramer and
trimer lacking p12, or even core dimer might occur in vivo, if not
all, at least partially. We previously gave a proposed model for the
interactions between pol d subunits and PCNA based on the
suggestion that these contacts take place with a single PCNA
homotrimer [31]. Pol d might be able to interact with a single
molecule of PCNA homotrimer through its three subunits, p125,
p68, and p12. The fact that the p50 interacts with PCNA and
possible multi-arrangement of pol d adds to the complexity of this
issue. There remains an important question of how arrangements
of pol d and PCNA permit pol d to adopt flexible configurations
with PCNA in which its spatial orientation can be shifted between
several modes and both pol d and PCNA play a role in different
DNA transactions. Here, we proposed a model of network for
protein-protein interactions of pol d subassemblies-PCNA com-
plexes to include p50 in which pol d interacts with PCNA via its
four subunits as shown in Figure 8.
In this model, the interactions between pol d and PCNA
subunits are shown with the assumption in which these contacts
take place with a single PCNA homotrimer. In the complete
structure, six of the seven participants are each involved in three
protein-protein interactions (Figure 8A). P50 is excluded from the
interaction with PCNA because of its weaker binding to PCNA. In
this case, whether the p50 subunit is involved in other DNA
transactions and the nature of its role are still unknown. Removal
of p12 or p68 converts the interaction network to one in which p50
provides an alternative interaction with one monomer of PCNA
homotrimer, retaining three trivalent interactions of PCNA
monomers (Figure 8B and 8C). While in the case of removal of
both p12 and p68, the interaction network would convert to one in
which only two PCNA monomers retain trivalent interactions
(Figure 8D). This conversion results in one PCNA monomer free
from the interaction with pol d, which may permit a flexible
configuration between pol d and PCNA in which its spatial
orientation can be shifted between several modes. Based on this
model, we would argue that p50 may play an important role in
converting pol d and PCNA into an integrated assembly. We still
could not get a conclusion of which, p50, or p68, or both, is mainly
required to mediate the interaction between pol d and PCNA.
Mammalian p125 has been shown to bind to PCNA. However,
the question of whether the p125 interaction with PCNA is also
engaged in the pol d-PCNA complex remains to be experimentally
verified. Here, our prospective model may be incomplete or only
partially correct but does provide a novel perspective of pol d-
PCNA interactions and p50 may be required to mediate the
interaction of pol d with PCNA.
In summary, we have confirmed that the p50 weakly binds to
PCNA by far-Western analysis, quantitative ELISA assay, and
subcellular localization. P50 may play a role in mediation of the
interaction between pol d subcomplexes and PCNA by the
examination of the network of interactions in a proposed model of
the PCNA-pol d as an integrated structure.
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